Flora Growth 2025 Q3 Earnings Widened Net Loss of $6.66M Despite 34.7% Revenue Growth

Flora Growth (FLGC) reported fiscal 2025 Q3 results on November 6, 2025, showing a 34.7% year-over-year revenue increase to $9.75 million but a significantly widened net loss. The company underperformed both revenue and earnings estimates, with shares dropping sharply post-earnings.

Revenue

Driven by its Commercial & Wholesale segment, which accounted for the entire $9.75 million in revenue, Flora Growth reported a 34.7% year-over-year increase. This growth follows a 2024 Q3 revenue of $7.24 million.

Earnings/Net Income

Flora Growth narrowed its per-share loss to $9.05 in Q3 2025 from $11.03 in 2024 Q3, an 18.0% improvement. However, the company’s net loss widened to $6.66 million, a 75.2% increase from the $3.80 million loss in 2024 Q3. While EPS improved, the net loss underscored persistent financial challenges.

Price Action

Flora Growth’s stock price declined 7.32% during the latest trading day and fell 8.21% during the most recent full trading week. The stock has plummeted 51.95% month-to-date, reflecting investor concerns over the company’s financial performance and outlook.

Post-Earnings Price Action Review

Following the earnings report, Flora Growth’s stock price declined 7.32% in the latest trading day and fell 8.21% during the most recent full trading week. The stock has plummeted 51.95% month-to-date, reflecting investor concerns over the company’s financial performance and outlook.

CEO Commentary

Flora Growth CEO highlighted the Q3 revenue achievement but noted operational challenges and cost pressures contributed to a $6.66 million net loss. Strategic priorities include optimizing production efficiency and expanding high-margin product lines. The CEO expressed cautious optimism about long-term innovation and cost discipline.

Guidance

Flora Growth did not provide explicit forward-looking quantitative guidance during the call. The CEO referenced ongoing efforts to align with long-term financial goals but offered no short-term metrics.

Additional News

No significant non-earnings related news was reported by Flora Growth within the three weeks following November 6, 2025. The company did not announce any mergers and acquisitions, executive changes, or dividend/buyback initiatives during this period. Shareholders remained focused on the company’s ongoing financial challenges and strategic initiatives outlined in the Q3 earnings report.